Aptiom is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by Sunovion Pharmaceuticals Inc.. The primary component is .
Product ID | 63402-248_05e586b4-1a22-4825-90e8-21053a1b570a |
NDC | 63402-248 |
Product Type | Human Prescription Drug |
Proprietary Name | Aptiom |
Generic Name | Eslicarbazepine Acetate |
Dosage Form | Kit |
Route of Administration | ORAL |
Marketing Start Date | 2014-04-07 |
Marketing Category | NDA / NDA |
Application Number | NDA022416 |
Labeler Name | Sunovion Pharmaceuticals Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2014-04-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022416 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-04-07 |
Marketing Category | NDA |
Application Number | NDA022416 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-04-07 |
SPL SET ID: | 3d0c9554-eaeb-4694-8089-00133fcadce3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63402-202 | Aptiom | ESLICARBAZEPINE ACETATE |
63402-204 | Aptiom | ESLICARBAZEPINE ACETATE |
63402-206 | Aptiom | ESLICARBAZEPINE ACETATE |
63402-208 | Aptiom | ESLICARBAZEPINE ACETATE |
63402-248 | Aptiom | ESLICARBAZEPINE ACETATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
APTIOM 86844180 5220839 Live/Registered |
Bial - Portela & Ca., S.A. 2015-12-09 |
APTIOM 86844154 5220838 Live/Registered |
Bial - Portela & Ca., S.A. 2015-12-09 |
APTIOM 86844123 5220837 Live/Registered |
Bial - Portela & Ca., S.A. 2015-12-09 |
APTIOM 86277162 not registered Live/Pending |
Bial - Portela & Ca., S.A. 2014-05-09 |
APTIOM 86277037 5655934 Live/Registered |
Bial - Portela & Ca., S.A. 2014-05-09 |
APTIOM 86276883 5348419 Live/Registered |
Bial - Portela & Ca., S.A. 2014-05-09 |
APTIOM 77655262 3727530 Live/Registered |
BIAL - PORTELA & CA., S.A. 2009-01-23 |